Comparison of an international scale method and a log reduction method for monitoring of early molecular response in chronic myeloid leukemia patients

被引:1
作者
Ahn, Sunhyun [1 ]
Lim, Young Ae [1 ]
Lee, Wee Gyo [1 ]
Jeong, Seong Hyun [2 ]
Park, Joon Seong [2 ]
Cho, Sung Ran [1 ]
机构
[1] Ajou Univ, Sch Med, Dept Lab Med, 164 World Cup Ro, Suwon 16499, South Korea
[2] Ajou Univ, Sch Med, Dept Hematol Oncol, Suwon, South Korea
关键词
D O I
10.5045/br.2016.51.1.58
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:58 / 61
页数:4
相关论文
共 15 条
[1]   Chronic Myeloid Leukemia: An Update of Concepts and Management Recommendations of European LeukemiaNet [J].
Baccarani, Michele ;
Cortes, Jorge ;
Pane, Fabrizio ;
Niederwieser, Dietger ;
Saglio, Giuseppe ;
Apperley, Jane ;
Cervantes, Francisco ;
Deininger, Michael ;
Gratwohl, Alois ;
Guilhot, Francois ;
Hochhaus, Andreas ;
Horowitz, Mary ;
Hughes, Timothy ;
Kantarjian, Hagop ;
Larson, Richard ;
Radich, Jerald ;
Simonsson, Bengt ;
Silver, Richard T. ;
Goldman, John ;
Hehlmann, Rudiger .
JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (35) :6041-6051
[2]   Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program [J].
Beillard, E ;
Pallisgaard, N ;
van der Velden, VHJ ;
Bi, W ;
Dee, R ;
van der Schoot, E ;
Delabesse, E ;
Macintyre, E ;
Gottardi, E ;
Saglio, G ;
Watzinger, F ;
Lion, T ;
van Dongen, JJM ;
Hokland, P ;
Gabert, J .
LEUKEMIA, 2003, 17 (12) :2474-2486
[3]   Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials [J].
Branford, Susan ;
Fletcher, Linda ;
Cross, Nicholas C. P. ;
Mueller, Martin C. ;
Hochhaus, Andreas ;
Kim, Dong-Wook ;
Radich, Jerald P. ;
Saglio, Giuseppe ;
Pane, Fabrizio ;
Kamel-Reid, Suzanne ;
Wang, Y. Lynn ;
Press, Richard D. ;
Lynch, Kevin ;
Rudzki, Zbigniew ;
Goldman, John M. ;
Hughes, Timothy .
BLOOD, 2008, 112 (08) :3330-3338
[4]   Standardized definitions of molecular response in chronic myeloid leukemia [J].
Cross, N. C. P. ;
White, H. E. ;
Mueller, M. C. ;
Saglio, G. ;
Hochhaus, A. .
LEUKEMIA, 2012, 26 (10) :2172-2175
[5]   Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia [J].
Druker, Brian J. ;
Guilhot, Francois ;
O'Brien, Stephen G. ;
Gathmann, Insa ;
Kantarjian, Hagop ;
Gattermann, Norbert ;
Deininger, Michael W. N. ;
Silver, Richard T. ;
Goldman, John M. ;
Stone, Richard M. ;
Cervantes, Francisco ;
Hochhaus, Andreas ;
Powell, Bayard L. ;
Gabrilove, Janice L. ;
Rousselot, Philippe ;
Reiffers, Josy ;
Cornelissen, Jan J. ;
Hughes, Timothy ;
Agis, Hermine ;
Fischer, Thomas ;
Verhoef, Gregor ;
Shepherd, John ;
Saglio, Giuseppe ;
Gratwohl, Alois ;
Nielsen, Johan L. ;
Radich, Jerald P. ;
Simonsson, Bengt ;
Taylor, Kerry ;
Baccarani, Michele ;
So, Charlene ;
Letvak, Laurie ;
Larson, Richard A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (23) :2408-2417
[6]   Molecular Resistance: An Early Indicator for Treatment Change? [J].
Fava, Carmen ;
Kantarjian, Hagop ;
Cortes, Jorge .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2012, 12 (02) :79-87
[7]   Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia -: A Europe Against Cancer Program [J].
Gabert, J ;
Beillard, E ;
van der Velden, VHJ ;
Bi, W ;
Grimwade, D ;
Pallisgaard, N ;
Barbany, G ;
Cazzaniga, G ;
Cayuela, JM ;
Cavé, H ;
Pane, F ;
Aerts, JLE ;
De Micheli, D ;
Thirion, X ;
Pradel, V ;
González, M ;
Viehmann, S ;
Malec, M ;
Saglio, G ;
van Dongen, JJM .
LEUKEMIA, 2003, 17 (12) :2318-2357
[8]   Early molecular and cytogenetic response is predictive for long-term progression-free and overall survival in chronic myeloid leukemia (CML) [J].
Hanfstein, B. ;
Mueller, M. C. ;
Hehlmann, R. ;
Erben, P. ;
Lauseker, M. ;
Fabarius, A. ;
Schnittger, S. ;
Haferlach, C. ;
Goehring, G. ;
Proetel, U. ;
Kolb, H-J ;
Krause, S. W. ;
Hofmann, W-K ;
Schubert, J. ;
Einsele, H. ;
Dengler, J. ;
Haenel, M. ;
Falge, C. ;
Kanz, L. ;
Neubauer, A. ;
Kneba, M. ;
Stegelmann, F. ;
Pfreundschuh, M. ;
Waller, C. F. ;
Branford, S. ;
Hughes, T. P. ;
Spiekermann, K. ;
Baerlocher, G. M. ;
Pfirrmann, M. ;
Hasford, J. ;
Saussele, S. ;
Hochhaus, A. .
LEUKEMIA, 2012, 26 (09) :2096-2102
[9]   Monitoring CML patients responding to treatment with tyrosine kinase inhibitors:: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results [J].
Hughes, Timothy ;
Deininger, Michael ;
Hochhaus, Andreas ;
Branford, Susan ;
Radich, Jerald ;
Kaecla, Jaspal ;
Baccarani, Michele ;
Cortes, Jorge ;
Cross, Nicholas C. P. ;
Druker, Brian J. ;
Gabert, Jean ;
Grimwade, David ;
Hehlmann, Ruediger ;
Kamel-Reid, Suzanne ;
Lipton, Jeffrey H. ;
Longtine, Janina ;
Martinelli, Giovanni ;
Saglio, Giuseppe ;
Soverini, Simona ;
Stock, Wendy ;
Goldman, John M. .
BLOOD, 2006, 108 (01) :28-37
[10]   Frequency of major molecular responses to imatinib or interferon alfa plus cytarabine in newly diagnosed chronic myeloid leukemia [J].
Hughes, TP ;
Kaeda, J ;
Branford, S ;
Rudzki, Z ;
Hochhaus, A ;
Hensley, ML ;
Gathmann, I ;
Bolton, AE ;
van Hoomissen, IC ;
Goldman, JM ;
Radich, JP ;
Taylor, K ;
Durrant, S ;
Schwarer, A ;
Joske, D ;
Seymour, J ;
Grigg, A ;
Ma, D ;
Arthur, C ;
Bradstock, K ;
Joshua, D ;
Lechner, K ;
Verhoef, G ;
Louwagie, A ;
Martiat, P ;
Straetmans, N ;
Bosly, A ;
Shepherd, J ;
Shustik, C ;
Lipton, J ;
Kovacs, DM ;
Turner, AR ;
Nielsen, JL ;
Birgens, H ;
Bjerrum, OW ;
Guilhot, F ;
Reiffers, J ;
Rousselot, P ;
Facon, T ;
Harousseau, JL ;
Tulliez, M ;
Guerci, A ;
Blaise, D ;
Maloisel, F ;
Michallet, M ;
Fischer, T ;
Hossfeld, D ;
Mertelsmann, R ;
Andreesen, R ;
Nerl, C .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (15) :1423-1432